An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy and safety of LYC-30937-EC given orally
once daily in subjects with active ulcerative colitis (UC) defined as a total Mayo score
(TMS) of 4-11 inclusive, with an endoscopic score of ≥ 2 and a rectal bleeding score of ≥ 1
at screening.